Interactions between antimicrobial drugs and phagocytes: an overview

International Journal of Antimicrobial Agents

Volumn 3, Issue 2, 1993, Pages 73-87

  Labro, M T ^a  

^a INSERM   (France)

Author keywords

Antimicrobial agents; Immunomodulation; Phagocyte

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMODIAQUINE; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CHLOROQUINE; CLINDAMYCIN; COTRIMOXAZOLE; DAPSONE; FUSIDIC ACID; IMIPENEM; ISONIAZID; MACROLIDE; MALOPRIM; MEPACRINE; MEROPENEM; METRONIDAZOLE; PENICILLIN DERIVATIVE; PYRIMETHAMINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TEICOPLANIN; TETRACYCLINE; TRIMETHOPRIM; UNINDEXED DRUG;

APLASTIC ANEMIA; BACTERICIDAL ACTIVITY; GRANULOCYTOPENIA; HOST RESISTANCE; HUMAN; IMMUNE DEFICIENCY; IMMUNOMODULATION; INFECTION; PHAGOCYTE; PHAGOCYTOSIS; REVIEW;

EID: 0027421459     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-8579(93)90017-Y     Document Type: Article

References (134)

1. Roles of the neutrophil and other mediators in adult respiratory distress syndrome
2. Bacterial virulence and the inflammatory system
3. New aspects of antimicrobial resistance and the resulting therapeutic dilemmas
4. The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections
5. Antibiotics as biological response modifers
6. The biology of the monocytes system
7. Effects of antimicrobial and antineoplastic drugs on the phagocytic and microbicidal function of the polymorphonuclear leukocyte
8. Antimicrobial drugs, microorganisms and phagocytes
9. Effects of anti-infectious agents on polymorphonuclear neutrophils
10. The antibacterial effects of low concentrations of antibiotics and host deference factors: a review
11. Low concentrations of antibiotics
12. Post antibiotic leukocyte enhancement: increased susceptibility of bacteria pretreated with antibiotics to activity of leukocytes
13. Drug-induced auto-immune and hematologic disorders
14. Drug-induced a plastic anaemia and agranulocytosis. Incidence and mechanisms
15. Drug-induced agranulocytosis. Peripheral destruction of polymorphonuclear leokocytes and their marrow precursors
16. Chloramphenicol-induced bone marrow injury possible role of bacterial metabolites of chloramphenicol
17. Inhibition of granulopoiesis in vivo and in vitro by β-lactam antibiotics
18. Effect of β-lactam antibiotics on proliferating eucaryotic cells
19. Ceftriaxone-induced granulopenia related to a peculiar mechanism of granulopoiesis inhibition
20. High incidence of severe neutropenia associated with amodiaquine prophylaxis for malaria
21. Amodiaquine-induced agranulocytosis: toxic effects of amodiaquine in bone marrow cultures in vitro
22. The toxicity of amodiaquine and its principal metabolite leukocytes and granulocyte/monocyte colony forming units
23. Detection of antidrug IgG antibodies in patients with adverse drug reaction to aminodiaquine
24. Mechanisms of formation of protein-arylating intermediates from amodiaquine, a myelotoxin and hepatoxin in man
25. Agranulocytosis during treatment with mefloquine
26. Influence of two antimalarials chloroquine and mefloquine on human myelopoiesis in vitro
27. Mechanisms of hypersensitivity reactions: proposed involvement of reactive metabolites generated by activated leukocytes
28. Molec Pharmacol
29. Use of a metabolic inhibitor to reduce dapsone-dependent haematological toxicity
30. Ciprofloxacin inhibitors human hematopoietic cell growth: synergism with tumor necrosis factor and interferon
31. Implications of intracellular residence of microorganisms for antibiotic therapy
32. Comparative biology of intracellular parasitism
33. Intracellular parasitism
34. Interaction of the oxygen-dependent antimicrobial system of the human neutrophil with difloxacin ciprofloaxin pefloxacin and fleroxacin in the intraphagocytic eradication of Staphylococcus aureus
35. An in-vitro investigation on the intracellular bioactivity of amoxycillin, clindamycin and erythromycin for Staphylococcus aureus
36. Synergistic bactericididal interaction of josamycin with human neutrophils in vitro
37. Antibacterial synergy betwern dirithromycin, erythromycylamine, roxithromycin, and neutrophils
38. Bioactivité intracellulaire des antibiotiques
39. Intraphagocytic penetration of macrolides
40. High-performance liquid chromatography measurement of antimicrobial concentrations in polymorphonuclear leukocytes
41. Effects of phagocytosis on antibiotic and nucleoside uptake by human polymorphonuclear leukocytes
42. Intracellular distribution and activity of antibiotics
43. Quinine uptake by human polymorphonuclear neutrophils
44. Uptake and activity of rifapentine in human peritoneal macrophages and polymorphonuclear leukocytes
45. Entry of roxithromycin (RU 965), imipenem, cefotaxime, tripmethoprim and metronidazole into human polymorphonuclear leukocytes
46. J774 macrophages secrete antibiotics via organic anion transporters
47. Phagocytes, antibiotics and intracellular parasites: are the experimental data clinically relevant?
48. In vitro demonsntration of transport and delivery of antibiotics by polymorphonuclear leukocytes
49. Activity of antibiotics against microorganisms ingested by mononuclear phagocytes
50. The anti-bacterial activity of benzylpenicillin against Staphylococcus aureus ingested by granulocytes
51. Effects of ampicillin, ceftriaxone, chloramphenicl, pefloxacin and trimethoprim-sulphamethoxazole on Salmonella typhi within human monocyte-derived macrophages
52. Effects of cefotaxime on neutrophil and lymphocyte functions
53. Immunological by antibacterial agents. Is it clinically relevant?
54. Modulation of phagocyte function by antibiotics and other drugs present status and future perspective
55. Receptors and intracellular signalling in humn neutrophils
56. GTP binding proteins and signal transduction in the human neutrophil
57. Activation and regulation of protein kinase C enzymes
58. Second messengers derived from inositol lipids
59. Oxygen-dependent microbial killing by phagocytes
60. Oxidants from phagocytes: agents of defense and destruction
61. The role of oxygen and its derivatives in microbial pathogenesis and host defence
62. Antibiotic proteins of human neutrophils
63. Oxygen radicals—an important mediator of sepsis and septic shock
64. The presence of neutrophil elastase and evidence of oxidation acticity in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome
65. Rifampin affects polymorphonuclear leukocyte interactions with bacterial and synthethic chemotaxins but not interactions with serum-derived chemotaxins
66. The effects of antibacterial drugs on neutrophil function
67. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones
68. Cefodizime (HR 221) potentiation of human neutrophil exygen-independent bactericidal activity
69. Interaction of cefotamine versus desacetyl cefotamine on human neutrophil functions
70. Effects of antibiotics on polymorphonuclear leukocyte chemiluminescence and chemotaxis
71. Influence of forty-two antimicrobial agents on the chemiluminescence response of human phagocytic cells
72. Influence of various antimicrobial agents on the chemiluminescence of phagocytosing human granulocytes
73. Effects of clindamycin and cefuroxime on leukocyte membrane receptors and function
74. In vivo and in vitro effects of doxycycline on leucocyte membrane receptors
75. Antibiotics and human monocyte function. II. Phagocytosis and oxidative metabolism
76. Fusidic acid and human phagocyte function
77. Enhancement of macrophage superoxide anion production by amphotericin B
78. Effects of polyene antibiotics on the activation of human polymorphonuclear leukocyte
79. Comparison of the in vitro effect of several macrolides on the oxidative burst of human neutrophils
80. Effect of monodesethyl amodiaquine on human polymorphonuclear neutrophil function in vitro
81. Effect of tetracycline and UV light on oxygen consumption by human leukocytes
82. Tetracycline as antixydants in rheumatoid arthritis: scavenging of hypochlorous acid
83. Specificity of the anticollagenase action of tetracycline: relevance to their anti-inflammatory potential
84. Inhibition of polymorphonuclear leukocyte functions by chlortetracycline
85. Aminoglycoside-induced alterations of phosphoinositide metabolism
86. Inhibition of lysosomal phospholipases by aminoglycosides antibiotics in vitro comparative studies
87. Effect of aminoglycoside antibiotics on polymorphonuclear leukocyte function in vivo
88. Effects of polymysix B on superoxide anion release and priming in human polymorphonuclear leukocytes
89. Effects of amodiaquine, chloroquine and mefloquine on human polymorphonuclear neutrophil function in vitro
90. Inhibition of human neutrophil protein kinase C activity by the antimalarial drug mefloquine
91. Apparent involvement of phospholipase A2 but not protein kinase C in the prooxidative interactions of clofazimine with human phagocytes
92. Investigation of the structural properties of dihydrophenazines which contribute to their pro-oxidative interactions with human phagocytes
93. Mechanisms by which clofazimine and dapsone inhibit the myeloperoxidase system
94. Mechanisms of action involved in the chemoattractant activity of three β-lactamic antibiotics upon human neutrophils
95. Stimulation of phagocytic processes and antibody-dependent cellular cytotoxicity of human neutrophils by cefmetazole
96. Effect of three β-lactam antibiotics on ascorbate content phagocytic activity and superoxide anion production in human neutrophils
97. Influence of antibiotics on formylmethionyl-leucyl-phenylalanine-induced leukocyte chemiluminescence
98. Cytoprotection against neutrophil-delivered oxidant attack by antibiotics
99. Uptake intracellular activity and influence of rifampin on normal function of polymorphonuclear leukocytes
100. Antimycobacterial drugs and the production of reactive oxidants by polymorphonuclear leucocytes in vitro
101. Isoniazid-mediated irreversible inhibition of the myeloperoxidase antimicrobial system of the human neutrophil and the effect of thyronines
102. CI-983 (Cefdinir) has different effect on polymorphonuclear neutrophil oxidative burst triggered by soluble and particulate stimuli
103. Effect of two antibiotics on human granulocyte activities
104. Ampicillin serves as an electron dono
105. DNA base damage by β-lactam, tetracycline, bacitracin and rifamycin antibacterial antibiotics
106. Effects of AC-1370 on phagocyte functions
107. Mechanism of action of AC-1370 on phagocyte functions
108. Cefodizime as a biological response modifier: a review of its in-vivo, ex-vivo and in-vitro immunomodulatory properties
109. Immunological evaluation of Cefodizime, a unique molecule among cephalosporins
110. Effects of macrolides on host natural defences
111. Comparative studies on the effects of erythormycin A and azithromycin upon extracellular release of lysosomal enzymes in inflammatory processes
112. Effect of quinine and cinchonine on human neutrophils in vitro
113. Effects of some antimalarial drugs on rat inflammatory polymorphonuclear leukocyte functions
114. Stimulation of human neutrophil degranulation of Mefloquine
115. Effect of Ciprofloxacin on phagocytosis
116. Effects of quinolones on granulocyte function in vitro
117. Superoxide generation in activated human neutrophils is accelerated by quinolone antibacterial agents
118. Effect of antibiotics on phagocytosis and bactericidal activity of human leucocytes
119. Effects of Cefaclor, Cefetamet and RO 40-706890 on inflammatory responses of human granulocytes
120. Non steroidal antiinflammatory agents in the therapy for experimental pneumococcal meningitis
121. Penicilline treatment accelerates middle ear inflammation in experimental pneumococcal otitis media
122. Treatement of pustular psoriasis with Clofazimine
123. Sulfones and sulfonamides in dermatology today
124. Pharmacologic actions of 4-aminoquinoline compounds
125. Lamprene (Clofazimine) in leprosy
126. Neutrophil chemotaxis in patients with acne receiving oral tetracycline therapy
127. The anti-inflammatory effect of erythromycin on zymosan-induced peritonitis of mice
128. Antiinflammatory effects antimicrobial agents
129. In-vivo and in-vitro interference of antibiotics with antigen-specific antibody responses: effect of Josamycin
130. Antibiotics and the immune system with special reference to Cefodizime
131. Intraphagocytic penetration of antibiotics